Efficacy Study of RX-10100 to Treat Major Depressive Disorder (MDD)

Clinical trial NCT00839176 · COMPLETED

Trial details

NCT number: NCT00839176
Sponsor: Rexahn Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder (MDD)

Start date: 2009-01-01
Primary completion: 2009-09-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.